Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sonny can’t die fast enough.
As crazy as Tesla is, he is spot on about Sint.
Definitely sell. Do not hold for the next reverse split.
They’ll amend and lower the offering price.
He doesn’t care. I honestly think it is intentional for his cronies.
To the $3’s, then the $2’s to back under a buck.
That’s just so they have a quorum for the RS vote. The vote has to be in line with how shareholders vote, his votes have to vote proportionally in line with how the shareholders vote.
Sorry, 52mil
Maintain Nasdaq compliance. It is currently around 46mil after recent offering.
Sonny sucks. Absolutely destroyed hard working peoples money. I hope the RS does not go through. No benefit of a RS at this point. After a 30-50:1 RS this is phucked. No one that bought 18 months ago will ever get their money back. Never ever.
There will be an opportunity to get out after the RS.
Well shoot? Hopefully his plane is exposed to some electromagnetic disturbance and falls out of the sky.
I’m pretty sure is is taking total control so he can protect us. It’s so nice to have a totalitarian leader who is always looking out for the company’s & our well-being
They legally have to give 21 days notice before AGM. Delaware incorporated business are required by law to have an AGM every 13 months.
Something has to give soon?
Thank goodness they drove this into the ground and did an offering.
Sonny Bal is a saint for protecting us from the dark forces.
25:1 at closing price gets it to around $3.5.
It’s trading below book and cash at the moment. Why would that magically change after a RS?
In 2019 it was a 30:1 and OS was less than 2 mil shares afterwards.
I thought for compliance it needs 10 days over $1. I didn’t think book value was a factor? Logical reasoning seems to have no place when factoring SiNtx’s valuation.
RS to $1.40 won’t hold 10 days. They’ll have to go more to make it.
Right now if they announced a RS in 10 days of 10:1 it would likely drop under a dime before the split took place. I think 20:1 minimum.
Maybe it gets great news, goes up, and the RS ratio goes down? Still some time I guess.
Are you completely disregarding the PPS and the upcoming dilution?
They have until early January for 10 consecutive biz days over $1. It’s not looking good unless something drastic happens, either a big money deal or big RS.
10:1 won’t be enough, at least 20:1. Maybe more. I think it will be closer to 50 than 20.
Still rings true over 2 years later.
I’ll get excited when something concrete happens that produces meaningful revenue. I would like to move beyond the speculation phase
Having a mask that inactivates the viral cause of a world wide pandemic is a pretty nice set up, yet these guys managed to fumble it. If they release the details from todays PR it would be helpful in gaining some credibility, given it is actually with a top tier company and the part is actually a critical component.
What if it isn’t?
I haven’t moved the bar. I want something big that will make them a self sustaining company (e.g. meaning revenue, profitability). If 30 to 1 RS’s and massive offerings are going to be the norm for the next decade then I will continue to bitch about Sintx management, B of D’s and their inability to run a financially healthy company.
Just to clarify: Name of the company that is paying, name of the part, and anticipated revenue & GM.
If it is similar to the current prosthetic revenue we would need about 50 more contracts to start to break even for operating expenses.
I don’t know that they have abandoned these things. More so not commercialized. Mask and dental implants are two that come to mind. I think there was something with Nissin too a few years ago.
I want names & numbers. Until then it doesn’t mean shit.
I haven’t seen any noteworthy revenue on the 10-Q’s and I haven’t heard about any products they are selling for revenue. Did I miss something?
I think if there is a years long scheme to erode investor confidence then Sonny is in on it. The inability to capitalize on the pandemic either means he acted with malice or stupidity. Also other failed ventures. He and the board own next to nothing in stock. Did they raise $100+ million dollars for research to make $100k a quarter like they do with Amedica?
It’s a business. business that don’t make a profit shouldn’t be around long. Somehow he keeps the doors open and doesn’t have to answer to his only revenue source (aka shareholders). All I’m saying is that he is a shitty CEO, that’s all. He has until the next RS to change my opinion. If the last one was 30:1 with only 50-60 mil OS, the next will be 50 (or more) to 1.
I’d still blame management for the lack of revenue and loss of investor confidence.
That ain’t happening. They are not terminating it. They have no good plan. Their plan is to dilute and RS.
Less thank 2cents. $1.4 mil into 80 mil shares. Holy shit man?
Given the tech and opportunities I am going with answer C. I hope that something terrible happens to the CEO. Maybe we’ll get lucky and his plan will fall from the sky due to magnetic disturbances.
It could cure cancer, ED, baldness, and depression with dozens of outstanding NDA’s, and still not come to market with a product.
It doesn’t matter really. They’re not going to commercialize anything that would make them any money :(.
They have enough cash for 2022. $14 mil on hand as of 12-31-2021 per their 10k filing.
“Schrödinger's Schlong theory”
Hilarious
Essentially yes. I don’t care how they go about it.
We couldn’t get lucky enough. 225 would put pps between $8-$9